
Exact Sciences Corporation EXAS
€ 87.69
0.35%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Exact Sciences Corporation EV 2011-2026 | EXAS
EV Jährlich Exact Sciences Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.2 B | 14 B | 13.8 B | 16.1 B | 21.3 B | 13.3 B | 11.4 B | 5.73 B | 1.84 B | 602 M | 2.15 B | 901 M | 644 M | 456 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.3 B | 456 M | 8.18 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 23.35 | -0.21 % | $ 251 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 23.27 | 0.78 % | $ 99.4 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.59 | -0.94 % | $ 2.02 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 235.37 | 0.14 % | $ 172 B | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.04 | -6.67 % | $ 342 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 6.09 | -0.49 % | $ 179 M | ||
|
DexCom
DXCM
|
52.4 B | $ 67.79 | -0.94 % | $ 26.2 B | ||
|
Castle Biosciences
CSTL
|
665 M | $ 39.08 | -2.03 % | $ 1.09 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 17.15 | -0.44 % | $ 922 M | ||
|
Celcuity
CELC
|
506 M | $ 105.14 | 0.45 % | $ 4.15 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.42 | - | $ 109 K | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 27.97 | 0.29 % | $ 846 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 245.35 | 0.9 % | $ 44.5 B | ||
|
RadNet
RDNT
|
5.09 B | $ 78.75 | 0.47 % | $ 5.75 B | ||
|
Guardant Health
GH
|
6.94 B | $ 107.06 | -1.54 % | $ 13.1 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 141.04 | -3.29 % | $ 22.4 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 218.88 | 1.53 % | $ 11.2 B | ||
|
Natera
NTRA
|
5.53 B | $ 234.3 | -2.2 % | $ 23.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 175.68 | -1.19 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
142 M | $ 5.42 | -2.96 % | $ 703 M | ||
|
Pacific Biosciences of California
PACB
|
2.28 B | $ 2.03 | -0.49 % | $ 515 M | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 253.11 | -0.61 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 183.94 | -2.27 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 712.09 | -0.04 % | $ 58.7 B | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.5 | -2.0 % | $ 4.6 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 148.13 | 1.63 % | $ 45 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.74 | -4.79 % | $ 6.29 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | $ 48.1 | -0.72 % | $ 10.7 B | ||
|
Bioventus
BVS
|
904 M | $ 7.86 | -1.75 % | $ 492 M | ||
|
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 29.58 | 0.51 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
10.9 M | $ 25.52 | 10.53 % | $ 33.1 M |